Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Medical Sciences Journal ; (4): 303-308, 2022.
Artículo en Inglés | WPRIM | ID: wpr-970696

RESUMEN

Objective Total knee arthroplasty is one of the most common orthopedic surgeries. Readmission due to severe complications after total knee arthroplasty is a grave concern to surgeons. In this study, we evaluated the risk factors for severe complications after primary total knee arthroplasty. Methods We retrospectively collected clinical data of 2,974 patients who underwent primary total knee arthroplasty from July 2013 to June 2019 in our hospital. Postoperative complication ≥ grade Ⅲ was defined as severe complication according to Clavien-Dindo classification system. Binary logistic regression was used to identify the predictive risk factors for severe complications. Results The complication rate after primary total knee arthroplasty was 6.8% and severe complication rate was 2.5%. Male (OR = 2.178, 95%CI: 1.324-3.585, P= 0.002), individuals above 75 years old (OR = 1.936, 95%CI: 1.155-3.244, P= 0.012), arrhythmia (OR = 2.913, 95%CI: 1.350-6.285, P= 0.006) and cerebrovascular disease (OR = 2.804, 95%CI: 1.432-5.489, P= 0.003) were predictive risk factors for severe complications after primary total knee arthroplasty. Conclusion Advanced age, male, arrhythmia, and cerebrovascular disease might be patients-related risk factors for postoperative severe complications after primary total knee arthroplasty. Special attention should be paid to patients with risk factors.


Asunto(s)
Humanos , Masculino , Anciano , Artroplastia de Reemplazo de Rodilla/métodos , Comorbilidad , Estudios Retrospectivos , Factores de Riesgo , Complicaciones Posoperatorias/etiología , Artroplastia de Reemplazo de Cadera/efectos adversos
2.
Chinese Medical Sciences Journal ; (4): 141-146, 2012.
Artículo en Inglés | WPRIM | ID: wpr-243248

RESUMEN

<p><b>OBJECTIVE</b>To assess Chinese surgeon practice of thromboprophylaxis following major orthopedic surgery.</p><p><b>METHODS</b>A questionnaire survey was conducted amongst Chinese orthopedic surgeons. A total of 293 surgeons were surveyed concerning five key aspects of thromboembolic prophylaxis after major orthopedic surgery at the proseminar of Chinese guidelines for prevention of venous thromboembolism (VTE) after major orthopedic surgery in January of 2009.</p><p><b>RESULTS</b>Totally, 208 surgeons (71.0%) responded, successfully completing the questionnaire. Of them, 57.6% respondents selected combined basic, mechanical, and pharmacologic methods for thromboprophylaxis; 51.0% respondents prefer starting prophylaxis 12-24 hours after surgery; 60.3% surgeons would use chemoprophylaxis for 7-10 days; 47.6% respondents prefer VTE prevention based on patients' special conditions and needs upon discharge."Safety" was the most repeated and emphasized factor during VTE prophylaxis.</p><p><b>CONCLUSIONS</b>Multimodal thromboprophylaxis is frequently used after major orthopedic surgery. Half surgeons prefer to start chemoprophylaxis 12-24 hours after surgery. Thromboprophylaxis regimen varies for discharged patients.</p>


Asunto(s)
Humanos , Heparina de Bajo-Peso-Molecular , Usos Terapéuticos , Procedimientos Ortopédicos , Ortopedia , Complicaciones Posoperatorias , Encuestas y Cuestionarios , Tromboembolia
3.
Chinese Medical Sciences Journal ; (4): 221-226, 2011.
Artículo en Inglés | WPRIM | ID: wpr-299381

RESUMEN

<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of low molecular weight heparin (LMWH) prophylaxis for venous thromboembolism (VTE) after lumbar decompression surgery.</p><p><b>METHODS</b>Patients at high or the highest risk of VTE who underwent lumbar spine surgery in Peking Union Medical College Hospital from January 2004 to April 2011 were included in the present study. All the patients received a half dose of LMWH 6 hours after surgery followed by a full dose LMWH once per day until discharge. We recorded incidences of deep venous thrombosis (DVT), pulmonary embolism (PE), bleeding complications, and medication side effects.</p><p><b>RESULTS</b>Seventy-eight consecutive patients were eligible and enrolled in this study. The mean hospital stat was 8.5±4.5 days. No symptomatic DVT, PE, or major bleeding events were observed. One patient developed wound ecchymosis, another developed wound bleeding, four had mild hepatic aminotransferase level elevation, and one developed a suspicious allergic reaction.</p><p><b>CONCLUSION</b>LMWH may be applied as an effective and safe prophylaxis for VTE in high-risk patients undergoing lumbar decompression surgery.</p>


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Descompresión Quirúrgica , Heparina de Bajo-Peso-Molecular , Usos Terapéuticos , Vértebras Lumbares , Cirugía General , Tromboembolia Venosa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA